Market Overview:
The global enzymatic debridement ointment market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of chronic wounds, rising demand for minimally invasive procedures, and technological advancements in wound care products. Based on type, the global enzymatic debridement ointment market is segmented into collagenase product, papain product, and others. The collagenase product segment is expected to account for the largest share of the global enzymatic debridement ointment market in 2018. This segment is projected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030 due to its ability to effectively remove dead tissue from wounds without causing any damage or pain. Based on application, the global enzymatic debridement ointment market is divided into hospitals, clinics, and others segments. The hospitals segment accounted for majority share of revenue generated by this market in 2017 and it is projected that this trend will continue duringthe forecast period as well owingto increase incidences offoreign body injuriesand other acute injuries which require surgical intervention followed by use oftissue-debriding agents such as enzymes.
Product Definition:
Enzymatic debridement ointment is a topical agent that is used to remove dead or damaged skin cells. It can be used to treat a variety of skin conditions, such as psoriasis, eczema, and dermatitis. Enzymatic debridement ointment can also be used to help improve the appearance of scars.
Collagenase Product:
Collagenase is a protein-digesting enzyme that is produced by the skin and bone marrow of animals and humans. It has been used in enzymatic debridement ointments for several decades. The main function of these ointments is to allow rapid wound healing by removing the top layer of dead cells, which adheres to the wound surface, thereby making it easier for new tissue to grow over the open wounds.
Papain Product:
Papain is a proteolytic enzyme that is obtained from the Papaya tree. It works by digesting proteins and other non-vital tissues in the body. The ointment contains 2% to 5% concentration of papain product, which helps in softening and dissolving necrotic tissue through enzymatic activity.
Application Insights:
Based on the application, the global enzymatic debridement ointment market is segmented into hospitals, clinics and others. The hospitals segment dominated the market in 2017 owing to increasing cases of burn injuries and trauma across all regions. In addition, a rise in number of surgeries is expected to propel demand for DEBOMID over the forecast period.
The clinics application segment is anticipated to witness lucrative growth over the forecast period due to rising awareness about preventable diseases along with increasing disposable income levels among people globally.
Regional Analysis:
North America dominated the global enzymatic debridement ointment market in 2017. The presence of well-established healthcare infrastructure and high adoption rate of advanced therapeutics are some factors responsible for its large share. In addition, increasing incidence of sports injuries and rising number of burn cases due to various accidents are also expected to drive the regional market over the forecast period.
Asia Pacific is expected to be one of the fastest-growing regions during the forecast years owing to untapped opportunities in this region. Increasing prevalence diabetes, cardiovascular diseases, arthritis, trauma & burns injuries), along with rising awareness about early diagnosis among patients is driving growth in this region. Moreover, growing medical tourism industry due to affordable treatment options will also boost demand for enzymatic debridement ointments in Asia Pacific region over next few years (8).
Growth Factors:
- Increasing incidence of chronic wounds: The increasing incidence of chronic wounds is one of the key growth drivers for the enzymatic debridement ointment market. According to a study by the National Institute of Health, around 6.7 million people in the U.S are affected by chronic wounds every year, which is likely to increase in future due to rising geriatric population and increasing prevalence of diabetes and obesity. This will create demand for effective wound care products such as enzymatic debridement ointments, thereby driving market growth.
- Rising awareness about benefits of enzymatic debridement: There is growing awareness among healthcare professionals and patients about the benefits of enzymatic debridement over traditional methods such as sharp or surgical debridement. This is helping to drive demand for enzymatic debridement ointments, thereby propelling market growth.
Scope Of The Report
Report Attributes
Report Details
Report Title
Enzymatic Debridement Ointment Market Research Report
By Type
Collagenase Product, Papain Product, Others
By Application
Hospitals, Clinics, Others
By Companies
Smith & Nephew, Stratus Pharma, WeiBang Biopharm, MediWound, Virchow
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
137
Number of Tables & Figures
96
Customization Available
Yes, the report can be customized as per your need.
Global Enzymatic Debridement Ointment Market Report Segments:
The global Enzymatic Debridement Ointment market is segmented on the basis of:
Types
Collagenase Product, Papain Product, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Smith & Nephew
- Stratus Pharma
- WeiBang Biopharm
- MediWound
- Virchow
Highlights of The Enzymatic Debridement Ointment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Collagenase Product
- Papain Product
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Enzymatic Debridement Ointment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Enzymatic debridement ointment is a topical medication used to clean and remove dead skin cells from the surface of the body. It is typically applied to areas that are red, inflamed, or sore.
Some of the major companies in the enzymatic debridement ointment market are Smith & Nephew, Stratus Pharma, WeiBang Biopharm, MediWound, Virchow.
The enzymatic debridement ointment market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Enzymatic Debridement Ointment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Enzymatic Debridement Ointment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Enzymatic Debridement Ointment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Enzymatic Debridement Ointment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Enzymatic Debridement Ointment Market Size & Forecast, 2020-2028
4.5.1 Enzymatic Debridement Ointment Market Size and Y-o-Y Growth
4.5.2 Enzymatic Debridement Ointment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Collagenase Product
5.2.2 Papain Product
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Enzymatic Debridement Ointment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Enzymatic Debridement Ointment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Collagenase Product
9.6.2 Papain Product
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Collagenase Product
10.6.2 Papain Product
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Collagenase Product
11.6.2 Papain Product
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Collagenase Product
12.6.2 Papain Product
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Collagenase Product
13.6.2 Papain Product
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Enzymatic Debridement Ointment Market: Competitive Dashboard
14.2 Global Enzymatic Debridement Ointment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Smith & Nephew
14.3.2 Stratus Pharma
14.3.3 WeiBang Biopharm
14.3.4 MediWound
14.3.5 Virchow
